Utah medical cannabis sales reached $16.7 million in September, bringing the state’s total for 2026 to approximately $151.5 million, according to the newest monthly report from the Utah Department of Health and Human Services and Utah Department of Agriculture and Food, released today. This represents an increase of about $21.3 million, or 16.3%, compared with the same period in 2025.
September sales totaled $16,661,000 based on the product-category figures listed in the report. The total includes $8,272,000 in cartridges and pens, $5,483,500 in flower, $2,670,700 in infused edibles, $110,000 in infused non-edible products and $124,800 in non-medicated products.
Sales decreased by $334,500, or about 2%, from the $16,995,500 reported in August, but were 17.2% above total sales for September 2025.
Utah now has 117,285 patients with active medical cannabis cards, an increase of 127 from the 117,158 listed in the August report. The state also has 1,043 registered recommending medical providers, 148 paper-only recommending providers, 1,011 pharmacy agents, 990 processor or cultivator agents and 475 courier agents.
Among active patients, the largest age group was 31 to 40, with 30,502 patients, followed by those ages 41 to 50 at 26,238 and those ages 21 to 30 at 25,506. Patients 65 and older accounted for 13,268 cardholders.
Persistent pain remained by far the most common qualifying condition, with 102,787 patients, followed by PTSD with 5,408. Cancer, epilepsy, persistent muscle spasms and nausea were also among the qualifying conditions represented in the program.
The report shows 65,092 patients made at least one purchase during the previous 30 days, while 37,267 made two or more purchases and 22,663 made at least three. Over the previous 90 days, 90,375 patients made at least one purchase.
Utah cultivators also harvested more than 28,600 medical cannabis plants during September across 191 planting batches, representing approximately 18.95 million grams of cannabis biomass on a wet-weight basis.
Utah legalized medical cannabis in 2018, with the state’s first medical cannabis pharmacy opening in March 2020. The program does not allow recreational marijuana sales.
